A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Hoffmann-La Roche
Related studies linked through entity extraction aliases.
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
- Status
- RECRUITING
- Phase
- PHASE2
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevacizumab Plus Transarterial Chemoembolization
- Status
- COMPLETED
- Phase
- N/A
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study Evaluating Single-agent Inavolisib, Inavolisib Plus Atezolizumab, and Inavolisib Plus Pembrolizumab in PIK3CA-Mutated Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections
- Status
- COMPLETED
- Phase
- NA
NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors with Resectable Disease with Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H)
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
- Status
- RECRUITING
- Phase
- PHASE4
A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
- Status
- RECRUITING
- Phase
- NA
Davos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older Adults
- Status
- RECRUITING
- Phase
- NA